New Results
Sufficiency analysis of estrogen responsive enhancers using synthetic activators
Matthew Ginley-Hidinger, Julia B. Carleton, Adriana C. Rodriguez, Kristofer C. Berrett, Jason Gertz
doi: https://doi.org/10.1101/479709
Matthew Ginley-Hidinger
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
2Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA
Julia B. Carleton
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
3Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA
Adriana C. Rodriguez
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
3Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA
Kristofer C. Berrett
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
3Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA
Jason Gertz
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
3Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA
Posted September 17, 2019.
Sufficiency analysis of estrogen responsive enhancers using synthetic activators
Matthew Ginley-Hidinger, Julia B. Carleton, Adriana C. Rodriguez, Kristofer C. Berrett, Jason Gertz
bioRxiv 479709; doi: https://doi.org/10.1101/479709
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)